Severe Hyponatremia With Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials. OAIJMR 2025, 6 (1), 35-50. https://doi.org/10.37275/oaijmr.v6i1.826.